Guidant optimistic after heart failure device setback
This article was originally published in Clinica
Executive Summary
Following an unfavourable US FDA panel ruling on Guidant's heart failure (HF) device earlier this month, the company says it plans to provide further data and analysis to address the agency's concerns as early as July 20.